Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
PUT
Lemonade
LMND
$4.17B
| $152K | ﹤0.01% |
+11,100
| New | +$219K |
|
2177
Paymentus
PAY
$5.03B
| $152K | ﹤0.01% |
18,984
+3,186
| +20% | +$31.2K |
|
2178
CALL
Vertiv
VRT
$98.2B
| $149K | ﹤0.01% |
+10,900
| New | +$145K |
|
2179
Precigen
PGEN
$2.57B
| $147K | ﹤0.01% |
96,801
+22,965
| +31% | +$39.5K |
|
2180
Under Armour Class C
UA
$2.25B
| $147K | ﹤0.01% |
+16,435
| New | +$125K |
|
|
DX
2181
Dynex Capital
DX
$3.24B
| $146K | ﹤0.01% |
11,503
-91,209
| -89% | -$1.13M |
|
2182
Q32 Bio
QTTB
$487M
| $146K | ﹤0.01% |
6,424
| – | – |
|
2183
Alight
ALIT
$397M
| $145K | ﹤0.01% |
867
-352
| -29% | -$58.7K |
|
|
ETNB
2184
DELISTED
89bio
ETNB
| $142K | ﹤0.01% |
+11,142
| New | +$100K |
|
|
RCM
2185
DELISTED
R1 RCM Inc. Common Stock
RCM
| $142K | ﹤0.01% |
+12,990
| New | +$165K |
|
2186
Viking Therapeutics
VKTX
$3.88B
| $140K | ﹤0.01% |
+14,892
| New | +$66.5K |
|
|
MFGP
2187
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $140K | ﹤0.01% |
22,236
| – | – |
|
2188
CALL
Western Union
WU
$2.28B
| $139K | ﹤0.01% |
+10,100
| New | +$139K |
|
|
MTCR
2189
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $139K | ﹤0.01% |
310,027
-39,073
| -11% | -$16.2K |
|
2190
First Watch Restaurant Group
FWRG
$813M
| $138K | ﹤0.01% |
+10,173
| New | +$155K |
|
2191
Goodyear
GT
$1.73B
| $137K | ﹤0.01% |
+13,484
| New | +$147K |
|
2192
Scholar Rock
SRRK
$7.09B
| $135K | ﹤0.01% |
14,892
-2,435
| -14% | -$19.5K |
|
|
GAP
2193
CALL
The Gap Inc
GAP
$7.33B
| $135K | ﹤0.01% |
+11,900
| New | +$142K |
|
2194
Seer Inc
SEER
$113M
| $134K | ﹤0.01% |
23,125
-21,325
| -48% | -$144K |
|
2195
Coeur Mining
CDE
$21.5B
| $132K | ﹤0.01% |
39,332
-47,798
| -55% | -$170K |
|
|
SNCR
2196
DELISTED
Synchronoss Technologies
SNCR
| $130K | ﹤0.01% |
23,333
| – | – |
|
2197
Applovin
APP
$99.9B
| $128K | ﹤0.01% |
12,144
-21,356
| -64% | -$313K |
|
2198
Lyft
LYFT
$6.69B
| $127K | ﹤0.01% |
11,504
-188,425
| -94% | -$2.27M |
|
2199
Rayonier Advanced Materials
RYAM
$563M
| $126K | ﹤0.01% |
+13,102
| New | +$83.4K |
|
|
TCS
2200
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $125K | ﹤0.01% |
+1,941
| New | +$140K |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.